Provided by Tiger Trade Technology Pte. Ltd.

Macrogenics

4.02
-0.0800-1.95%
Post-market: 4.020.00000.00%16:20 EDT
Volume:432.52K
Turnover:1.74M
Market Cap:255.86M
PE:-17.55
High:4.08
Open:4.07
Low:3.97
Close:4.10
52wk High:5.08
52wk Low:1.29
Shares:63.65M
Float Shares:57.01M
Volume Ratio:1.01
T/O Rate:0.76%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-0.2291
EPS(LYR):-1.1815
ROE:-225.85%
ROA:-8.05%
PB:5.97
PE(LYR):-3.40

Loading ...

Macrogenics Flags Press Release on Mgc026 Phase 1 Study Update

Reuters
·
Jul 24

Macrogenics Provides Clinical Update on Ongoing Phase 1 Study for Mgc026

THOMSON REUTERS
·
Jul 24

MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026

GlobeNewswire
·
Jul 24

Entera Bio Leads Our Top 3 Penny Stocks To Consider

Simply Wall St.
·
Jul 22

Macrogenics Director Karen Ferrante to Resign Effective Sept. 1

Reuters
·
Jul 09

Macrogenics Sells GMP Manufacturing Operations to Bora Pharmaceuticals for $122.5 Million

Reuters
·
Jul 08

Bora Pharmaceuticals Completes Acquisition of Macrogenics Biologics CDMO Assets in Maryland

Reuters
·
Jul 02

Macrogenics Sells GMP Manufacturing Operations to Bora for $122.5 Million

Reuters
·
Jul 02

Macrogenics Completes Sale of Gmp Manufacturing Operations to Bora Pharmaceuticals

THOMSON REUTERS
·
Jul 02

MacroGenics to Receive $24.5 Million in Regulatory Milestone Payment

MT Newswires Live
·
Jun 23

MacroGenics Inc: Will Receive a $24.5 Mln Regulatory Milestone Payment From Sanofi

THOMSON REUTERS
·
Jun 23

MacroGenics to Receive Milestone Payment From Sanofi for Recent Tzield® Approval

THOMSON REUTERS
·
Jun 23

MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval

GlobeNewswire
·
Jun 23

Analysts Offer Insights on Healthcare Companies: MacroGenics (MGNX), Bristol-Myers Squibb (BMY) and Pelthos Therapeutics (PTHS)

TIPRANKS
·
May 26

MacroGenics shareholders approved 1.25 million-share increase to 2023 equity plan

Reuters
·
May 21

Analysts Offer Insights on Healthcare Companies: ClearPoint Neuro (CLPT), Rapid Micro Biosystems (RPID) and MacroGenics (MGNX)

TIPRANKS
·
May 14

MacroGenics Inc reports results for the quarter ended December 31 - Earnings Summary

Reuters
·
May 14

Macrogenics Q1 EPS $(0.58) Beats $(0.65) Estimate, Sales $20.775M Beat $15.050M Estimate

Benzinga Earnings
·
May 14

MacroGenics Q1 revenue rises, beats estimates on client production and cancer drug royalties

Reuters
·
May 14

MacroGenics Q1 FY26 net loss narrows to $36.8 million; revenue rises to $20.8 million

Reuters
·
May 14